These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 19170030)
1. Use of mouse models for the analysis of human disease. Semsarian C Curr Protoc Hum Genet; 2009 Jan; Chapter 15():Unit 15.2. PubMed ID: 19170030 [TBL] [Abstract][Full Text] [Related]
2. Use of mouse models for the analysis of human disease. Semsarian C Curr Protoc Hum Genet; 2002 May; Chapter 15():Unit 15.2. PubMed ID: 18428327 [TBL] [Abstract][Full Text] [Related]
3. Engineering the mouse genome to model human disease for drug discovery. Koentgen F; Suess G; Naf D Methods Mol Biol; 2010; 602():55-77. PubMed ID: 20012392 [TBL] [Abstract][Full Text] [Related]
4. Genetic engineering in the mouse: tuning TNF/TNFR expression. Douni E; Alexiou M; Kollias G Methods Mol Med; 2004; 98():137-70. PubMed ID: 15064438 [TBL] [Abstract][Full Text] [Related]
5. [Genetically engineered mice and its application to bioindustry]. Koda T; Togashi Y; Nishimura T Hokkaido Igaku Zasshi; 2002 Mar; 77(2):151-6. PubMed ID: 11968850 [TBL] [Abstract][Full Text] [Related]
6. The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases. Linder CC Lab Anim (NY); 2001 May; 30(5):34-9. PubMed ID: 11385732 [TBL] [Abstract][Full Text] [Related]
7. [Genetically engineered mice: mouse models for cancer research]. Szymańska H Postepy Hig Med Dosw (Online); 2007 Oct; 61():639-45. PubMed ID: 17971765 [TBL] [Abstract][Full Text] [Related]
8. Practical development of genetically engineered animals as human disease models. Nomura T Lab Anim Sci; 1997 Apr; 47(2):113-7. PubMed ID: 9150486 [TBL] [Abstract][Full Text] [Related]
9. Genetically engineered models have advantages over xenografts for preclinical studies. Becher OJ; Holland EC Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152 [TBL] [Abstract][Full Text] [Related]
10. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226 [TBL] [Abstract][Full Text] [Related]
11. Technologically advanced cancer modeling in mice. Tuveson DA; Jacks T Curr Opin Genet Dev; 2002 Feb; 12(1):105-10. PubMed ID: 11790563 [TBL] [Abstract][Full Text] [Related]
12. Use of zebrafish models for the analysis of human disease. Zhu H; Zon LI Curr Protoc Hum Genet; 2002 Nov; Chapter 15():Unit 15.3. PubMed ID: 18428328 [TBL] [Abstract][Full Text] [Related]
13. Gene-engineered models for genetic manipulation and functional analysis of the cardiovascular system in mice. Chu PH; Lu JT; Chen J Chang Gung Med J; 2003 Dec; 26(12):868-78. PubMed ID: 15008321 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous and engineered mutant mice as models for experimental and comparative pathology: history, comparison, and developmental technology. Roths JB; Foxworth WB; McArthur MJ; Montgomery CA; Kier AB Lab Anim Sci; 1999 Feb; 49(1):12-34. PubMed ID: 10090091 [TBL] [Abstract][Full Text] [Related]
16. [Application and recent advances of laboratory mouse in human cancer research]. Liu EQ; Kitajima S; Morimoto M Ai Zheng; 2005 Feb; 24(2):249-54. PubMed ID: 15694046 [TBL] [Abstract][Full Text] [Related]